Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This open-labelled, single arm study is a follow-on from Study MPG010 to compare the relative
bioavailability of Lozanoc 65 mg Capsules against Lozanoc 50 mg Capsules and Sporanox 100 mg
Capsules in patients requiring itraconazole anti-fungal prophylaxis.